Quantcast
Home (page 2)

Tag Archives: Discovery

Yaz plaintiff loses bid to unseal documents for FDA

The Food and Drug Administration will not be given access to documents relating to the safety of drospirenone-containing oral contraceptives that pharmaceutical company Bayer has kept confidential in the Yaz and Yasmin multidistrict product liability litigation.

Read More »

Expert witness preparation after the 2010 amendments

Rule 26 of the Federal Rules of Civil Procedure, which broadly addresses the scope of permissible discovery and the basic rules of the road, has been thoroughly overhauled several times and tweaked almost continuously since its original inclusion in the ...

Read More »